arrow
J

Jose Carrillo

john wayne cancer institute
H指数:15
被引数:1,683

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival

Bota, D.A.; Piccioni, D.E.; Duma, C.M.; Kesari, S.; Carrillo, J.A.; LaRocca, R.V.; Aiken, R.D.; Taylor, T.H.; Abedi, M.; Robles, R.M.; 等. 新诊断胶质母细胞瘤的个性化树突状细胞疫苗2期试验:3年随访及与生存期的相关性. Hum. Vaccines Immunother. 2025, 21, 2556591. [Google Scholar] [CrossRef]

2025-12-313
PRE
FIRST-IN-HUMAN IMMUNOTHERAPY TARGETING LYMPHOPENIA IN RECURRENT GLIOBLASTOMA MULTIFORM (GBM): NAI AND PD-L1 T-HANK PLUS BEVACIZUMAB WITH COMPLETE RESPONSE

首次人体免疫疗法靶向复发性多形性胶质母细胞瘤(GBM)中的淋巴细胞减少症:NAI和PD-L1 T-HANK联合贝伐珠单抗实现完全缓解

2025-11-010
OAAI
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment
2022-12-1428
OAAI
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome
2013-01-1789
OAAI